Valuation Amarin Corporation plc Deutsche Boerse AG
Stocks
EH3
US0231114044
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
23:47:58 17/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 12.00 EUR | 0.00% |
|
+0.84% | +0.84% |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
| 09-08 | Amarin, Kruengkao Form JV to Expand Entertainment Business | MT |
Company Valuation: Amarin Corporation plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,333 | 488.6 | 355.2 | 199.5 | 290.2 | 293 | - | - |
| Change | - | -63.35% | -27.3% | -43.84% | 45.45% | 0.97% | - | - |
| Enterprise Value (EV) 1 | 1,114 | 270.4 | 156 | 78.46 | 155.5 | 130.7 | 118.1 | 113.9 |
| Change | - | -75.72% | -42.33% | -49.69% | 98.19% | -15.95% | -9.64% | -3.59% |
| P/E | 169x | -4.65x | -5.8x | -2.43x | -155x | -198x | -231x | -231x |
| PBR | 2x | 0.82x | 0.64x | 0.41x | - | 0.65x | 0.65x | 0.66x |
| PEG | - | 0x | 0.1x | -0.1x | 1.6x | 8.9x | 16.2x | - |
| Capitalization / Revenue | 2.29x | 1.32x | 1.16x | 0.87x | 1.36x | 1.65x | 1.66x | 1.71x |
| EV / Revenue | 1.91x | 0.73x | 0.51x | 0.34x | 0.73x | 0.74x | 0.67x | 0.66x |
| EV / EBITDA | 44.9x | -5.69x | -2.31x | -0.86x | -3.1x | -3.34x | -3.91x | -3.6x |
| EV / EBIT | 46x | -3.64x | -2.31x | -0.85x | -3.1x | -3.34x | -3.91x | -3.6x |
| EV / FCF | -16.7x | -1.5x | 22.7x | -2.53x | - | 5.23x | 9.08x | - |
| FCF Yield | -5.97% | -66.8% | 4.41% | -39.5% | - | 19.1% | 11% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.4 | -5.2 | -3 | -4 | -0.09 | -0.07 | -0.06 | -0.06 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 583.2 | 369.2 | 306.9 | 228.6 | 213.6 | 177.4 | 176.8 | 171.5 |
| EBITDA 1 | 24.81 | -47.5 | -67.43 | -91.7 | -50.17 | -39.16 | -30.2 | -31.62 |
| EBIT 1 | 24.22 | -74.26 | -67.59 | -91.8 | -50.17 | -39.16 | -30.2 | -31.62 |
| Net income 1 | 7.729 | -105.8 | -59.11 | -82.18 | -38.8 | -26.62 | -18.32 | -20.22 |
| Net Debt 1 | -219.5 | -218.2 | -199.3 | -121 | -134.7 | -162.3 | -174.9 | -179.1 |
| Reference price 2 | 67.40 | 24.20 | 17.40 | 9.70 | 13.96 | 13.87 | 13.87 | 13.87 |
| Nbr of stocks (in thousands) | 19,781 | 20,191 | 20,415 | 20,567 | 20,793 | 21,123 | - | - |
| Announcement Date | 01/03/22 | 01/03/23 | 29/02/24 | 12/03/25 | 25/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.48x | 7.21x | 14.48x | 1.45% | 69.69B | |
| 31.56x | 9.12x | 44.38x | 0.04% | 61.24B | |
| -74.83x | 14.47x | -69.78x | -.--% | 26.77B | |
| -14.57x | 5.25x | -6.6x | -.--% | 24.07B | |
| 27.63x | 5.23x | 17.38x | -.--% | 20.39B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.72B | |
| 17.54x | 5.22x | 12.19x | -.--% | 14.07B | |
| -14.86x | 3350.32x | -17.13x | -.--% | 13.8B | |
| -83.79x | 7.67x | -63.48x | -.--% | 12.22B | |
| Average | -5.04x | 380.13x | -3.86x | 0.2% | 28.66B | |
| Weighted average by Cap. | 5.05x | 187.42x | 6.77x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AMRN Stock
- EH3 Stock
- Valuation Amarin Corporation plc
Select your edition
All financial news and data tailored to specific country editions
